Drug abuse is a chronic disease that alters brain structure and function (
1). The non-medical use of opioids is a growing concern for public health and law enforcement (
2). Globally, 296 million people use drugs, with 60 million affected by opioids, and the problem is escalating (
3). In Iran, approximately 2 million people suffer from drug abuse disorders, highlighting the need for stronger prevention and treatment efforts (
4). Drug abuse affects an individual's activity as well as the proper function of the brain (
5). Accurate, rapid, and early assessments are crucial in identifying brain damage and preventing further secondary damage, facilitating treatment and rehabilitation (
6-
8).
The Bender-Gestalt test (BGT), developed by Lauretta Bender in 1938, is a visual-motor tool used to assess cognitive and motor skills by replicating geometric shapes (
9). The BGT clinical version (BGT-C) is particularly effective in detecting neurological impairments, offering a cost-effective, non-invasive alternative to brain imaging for early diagnosis and intervention (
10). The BGT is a widely used, quick, and accessible neuropsychological tool that reliably differentiates between organic and functional impairments in children and adults, remaining a key assessment tool in neurology (
10,
11). Bender selected nine forms from Wertheimer's famous 1923 paper for use in the test (
12). The growing issue of drug abuse raises public health concerns, increasing the risks of brain injuries, cognitive deficits, and functional impairments, thereby emphasizing the need to study its neuropsychological impact.
The documentation includes Bender's experiments with Gestalt's visuals. Bender began employing Wertheimer's designs before 1932, as noted by Billingslea (
13). Developed by Bender in 1940, the BGT assesses intelligence and detects functional or neurological impairments by having subjects copy nine geometric designs. Rooted in Gestalt psychology, it remains widely used despite numerous adaptations (
12). Drug abuse often leads to brain damage through direct effects, risky behaviors, infections, or poor lifestyles, emphasizing the need for early brain assessment in this group (
9). The BGT visual-motor test, rooted in Gestalt theory, was designed to assess children's maturational levels and is widely used by clinical psychologists to screen for neurological and neuropsychological issues (
14,
15). The most important features of the test include being abbreviated, non-verbal, standardized, and perceptual-motor. Non-verbal responses in this test have minimized cultural and socio-religious differences (
16). The BGT is used to detect organic brain damage by evaluating visual-motor function and perception function (
14). Drug abuse can cause brain damage, complicating assessment and treatment. While widely studied in psychiatric disorders, its impact on visual-motor functioning lacks research. Neuropsychological assessment is vital for prognosis, recovery evaluation, and guiding interventions (
17). The BGT assesses visual and motor abilities, often impaired in brain injuries, making it valuable for detecting neuropsychological abnormalities, which can be exacerbated by drug abuse (
10). In examining neuropsychology and drug abuse, studies have shown that after abusing marijuana, memory and concentration function are reduced (
18). den Hollander et al. showed that after abusing ecstasy, the volume of the hippocampus (long-term memory manager) is smaller, and generally, gray matter is lower (
19). Some studies suggest heroin alone may not cause neuropsychological disorders, but others indicate that combining it with other drugs or long-term use can lead to visual-motor impairment (
17,
20). Neuropsychological disorders have also been shown to occur after abusing methamphetamine in human samples (
21). Studies have shown that patients with drug abuse have a weaker performance in the BGT. Also, the use of BGT in screening people with drug abuse can prevent additional brain imaging (
20). The rationale for comparing BGT results between individuals with drug abuse and healthy individuals is to understand how drug abuse impacts neuropsychological performance. This study uses the BGT to compare neuropsychological performance between drug-abusing individuals and healthy controls, aiming to assess brain injury severity and improve early diagnosis. It hypothesizes that drug-abusing individuals will show more visual-motor errors and lower brain injury indices, enhancing understanding of drug abuse's neuropsychological impact.